{
  "retracted": false,
  "timestamp": 1561334400000,
  "updates": [
    {
      "timestamp": 1561390862013,
      "identifier": {
        "doi": "10.1186/s12885-019-5831-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s12885-019-5687-0"
  },
  "journal": "BMC Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine Â± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer"
}
